Login
Toggle navigation
Videos
Categories
Trending
COAL of Africa CEO Discusses Government Developments | John Wallington - CEO of Coal of Africa Ltd
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
john wallington is the ceo of coal of africa ltd
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Fred Lane, Managing Partner of Lane Generational at Raymond James, provides expert advice on wealth management and generational financial planning strategies.
00:10:00
AMBRA SA's Strong First Half: Revenue and Profit Growth Insights | Robert Ogór, President , AMBRA SA.
00:10:00
Goliath Mining CEO Discusses Growth Prospects and Exploration Successes at London Conference
00:10:00
Arjan Meijer Discusses New Embraer Turboprop | Arjan Meijer - CEO of Embraer
00:00:00
GeNeuro homes in on ancestral viral genes to treat autoimmune diseases - Jesús Martin-Garcia, Chief Executive Officer, Geneuro
00:10:00
Navigating Economic Slowdowns: Reassuring Trends in Savings, Spending, and Earnings | David Hefty - CHIEF EXECUTIVE OFFICER of Credent Wealth Management
00:10:00
Beleave Inc. CEO Andrew Wnek on Expanding Operations and Strategic Research Partnerships | Andrew Wnek, CEO, Beleave Inc.
00:10:00
A Tale of Innovation and Resilience in Penang's Manufacturing Sector | Chuah Choon Bin, Chairman, Pentamaster International Ltd
00:10:00
PDX Metals Advances Copper-Nickel Exploration at W2 and Gold Projects in Timmins
00:10:00
Goliath Resources: Exploring High-Potential Gold Targets in British Columbia's Golden Triangle
00:10:00
Interview with Misty Urbatsch, CEO of Core Nickel, at VRIC 2024 with Mark Bunting on RCTV | Misty Urbatsch, Chief Executive Officer, President & Director of Core Nickel
00:10:00
Navigating Global Markets: Key Insights on US Reporting Season and Investment Strategies